In oncology drug repurposing, bioavailability and route of administration represent the critical dividing line between in vitro laboratory efficacy and in vivo therapeutic success. Anthelmintic benzimidazoles (fenbendazole, mebendazole, and albendazole) were originally designed to treat luminal parasites within the gastrointestinal tract, meaning their chemical structures favor low systemic absorption and prolonged gut retention.
1. The Pharmacokinetic Barriers to Oral Bioavailability
Extremely Low Aqueous Solubility: Benzimidazoles are highly hydrophobic compounds with water solubility below 1 µg/mL (e.g., ~0.2–1.3 µg/mL for albendazole and ~0.3 µg/mL for fenbendazole), which severely impedes gastrointestinal dissolution.
Active Intestinal Efflux: In addition to poor dissolution, intestinal transport proteins—notably breast cancer resistance protein (BCRP / ABCG2)—actively pump absorbed benzimidazoles back into the intestinal lumen, limiting systemic entry.
High Fecal Excretion: In mammalian pharmacokinetic studies, more than 90% of orally administered fenbendazole is excreted unchanged in the feces. In cattle, 36% to over 50% of the oral dose is excreted unabsorbed or eliminated as hydroxyfenbendazole.
Low Baseline Human Bioavailability: In humans, oral bioavailability is reported to be 1% to <5% for albendazole and 5% to 10% (or 17–20% in tracer studies, falling to 1–2% after high doses) for mebendazole.
Extensive First-Pass Hepatic Clearance: The fraction that does cross the gut wall undergoes rapid first-pass metabolism by hepatic cytochrome P450 enzymes and flavin-containing monooxygenases. These biotransform parent drugs into active sulfoxides (e.g., oxfendazole, albendazole sulfoxide) and inactive hydroxylated metabolites (hydroxyfenbendazole, hydroxyalbendazole) mediated primarily by CYP2C19 and CYP2J2.
2. Dietary Strategies to Enhance Oral Administration
Because benzimidazoles are lipophilic, co-administration with dietary lipids dramatically alters absorption kinetics:
The “Fatty Meal” Effect: In humans and animal models, taking benzimidazoles alongside a high-fat meal enhances systemic absorption by up to 5-fold.


